ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 161128 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 161128; 2) Community: the network communities that were significantly associated with the response to NSC 161128; 3) Molecule: the relationships between components within communities and NSC 161128; 4) MDR: the compounds that were significantly associated with the NSC 161128.

NSC Compound Enrichment Correlation
NSC 111533 Methoxycamptothecin 0.0376362543535812 0.13504693
NSC 112152 2H,4aH-1,4,5-Trioxadicyclopent[a,hi]indene-7-carboxylic acid, 3-ethylidene-3,3a,7a,9b-tetrahydro-2-oxo-, methyl ester, [3aS-(3E,3a.alpha.,4a.beta.,7a.beta.,9aR*,9b.beta.)]- (9CI) 0.0376362543535812 0.46885856
NSC 269599 Stannane, chlorohydroxydiphenyl- 0.0376362543535815 0.41975669
NSC 294526 Null 0.0376362543535815 0.4035937
NSC 328166 8B-Hydroxy-9B,10B-epoxyverrucarin A 0.0376362543535815 0.25258359
NSC 354671 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2- thiazolyl)ethylidene]hydrazide 0.0376362543535815 0.50855373
NSC 363812 Tetraplatin 0.0376362543535815 0.38580117
NSC 39135 Null 0.0376362543535815 0.35176745
NSC 58239 A 80021F34 0.0376362543535815 0.29918591
NSC 630511 1,4-Benzoquinone-2-methoxy-5-dimethylaminomethyl- 6-(10-heptadecenyl)-(Z)-, hydrochloride 0.0376362543535815 0.50706077
Total:87  Current:64    [First] [Prev] [Next] [Last]